GI & Endoscopy

Fecal immunochemical testing is a noninvasive alternative to colonoscopy, but researchers at three U.S.-based universities are examining how effective the testing really is.

Pharmaceutical companies Pierre Fabre and Array BioPharma conducted a phase III trial evaluating a triple combination therapy for metastatic colorectal cancer patients, Labiotech reports.

With the release of the ASC Quality Reporting data for 2018, CMS allows users to search the average number of GI procedures performed per ASC by state.

Nebraska medical startup Virtual Incision Corp. completed an $18 million series B round of financing, Silicon Prairie News reports. Virtual Incision developed a surgical robot for colon resection, and the funds will go to manufacturing and clinical trials leading to…

CellMax Life published results from a study showing its circulating tumor cell blood test accurately detected colorectal cancer and precancerous lesions at an 87 percent and 77 percent accuracy rate, respectively. 

Pfizer surveyed ulcerative colitis patients and gastroenterologists finding that people living with UC are suffering from life-altering symptoms.

Here are the five most popular gastroenterology and endoscopy stories for the week of Jan. 15 to Jan. 19, 2018.

Here are 11 statistics on gastroenterology net revenue per case for ASCs, according to VMG Health's Multi-Specialty ASC Intellimarker 2017.

Michael Schulman, DO, is a gastroenterologist at Largo-based Florida Center for Gastroenterology.

Technology is one of the biggest complexities and costs for physician practices. The cost of running efficient, effective and compliant medical practices has become challenging for solo practitioners, small groups and even large groups across the country, driving consolidation among…